{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:14:37Z","timestamp":1792700077899,"version":"4.5.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian Pediatr"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s13312-011-0128-4","type":"journal-article","created":{"date-parts":[[2011,11,2]],"date-time":"2011-11-02T15:14:23Z","timestamp":1320246863000},"page":"779-784","source":"Crossref","is-referenced-by-count":14,"title":["Recombinant macrophage targeted enzyme replacement therapy for Gaucher disease in India"],"prefix":"10.1007","volume":"48","author":[{"given":"A.","family":"Nagral","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Mewawalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Jagadeesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kabra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. R.","family":"Phadke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. C.","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. D.","family":"Puri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. S.","family":"Kishnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. K.","family":"Mistry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,11,3]]},"reference":[{"key":"128_CR1","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3109\/10409239009090616","volume":"25","author":"G.A. Grabowski","year":"1990","unstructured":"Grabowski GA, Gatt S, Horowitz M. Acid beta-acid beta glucosidase: Enzymology and molecular biology of Gaucher disease. Crit Rev Biochem Mol Biol. 1990;25:385\u2013414.","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"128_CR2","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/archpedi.160.6.603","volume":"160","author":"P. Kaplan","year":"2006","unstructured":"Kaplan P, Andersson HC, Kacena KA, Yee JD. The clinical and demographic characteristics of nonneuronopathic Gaucher disease in 887 children at diagnosis. Arch Pediatr Adolesc Med. 2006;160:603\u2013608.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"128_CR3","first-page":"158","volume":"2","author":"R. Kauli","year":"2000","unstructured":"Kauli R, Zaizov R, Lazar L, Pertzelan A, Laron Z, Galatzer A, et al. Delayed growth and puberty in patients with Gaucher disease type 1: natural history and effect of splenectomy and\/or enzyme replacement therapy. Isr Med Assoc J. 2000;2:158\u2013163.","journal-title":"Isr Med Assoc J"},{"key":"128_CR4","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s00431-003-1362-0","volume":"163","author":"G.A. Grabowski","year":"2004","unstructured":"Grabowski GA, Andria G Baldellou A, Campbell PE, Charrow J, Cohen IJ, et al. Pediatric non-neuronopathic Gaucher disease: presentation, diagnosis and assessment: consensus statements. Eur J Pediatr. 2004;163:58\u201366.","journal-title":"Eur J Pediatr"},{"key":"128_CR5","unstructured":"Hopkin RJ, Grabowski GA. Lysosomal storage disease. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, et al. (eds). Harrison\u2019s Principles of Internal Medicine, 17th Edition:2008."},{"key":"128_CR6","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s10545-006-0121-6","volume":"29","author":"A. El-Beshlawy","year":"2006","unstructured":"El-Beshlawy A, Ragab L, Youssry I, Yakout K, El-Kiki H, Eid K, et al. Enzyme replacement therapy and bony changes in Egyptian paediatric Gaucher disease patients. J Inherit Metab Dis. 2006;29:92\u201398.","journal-title":"J Inherit Metab Dis"},{"key":"128_CR7","first-page":"83","volume":"11","author":"E.I. Ginns","year":"1983","unstructured":"Ginns EI, Erickson A, Tegelaers FP, Barneveld R, Reuser AJ, Brady RO, et al. Isozymes of beta-acid beta glucosidase: determination of Gaucher\u2019s disease phenotypes. Isozymes Curr Top Biol Med Res. 1983;11:83\u201399.","journal-title":"Isozymes Curr Top Biol Med Res"},{"key":"128_CR8","first-page":"686","volume":"38","author":"L. Kasturi","year":"2001","unstructured":"Kasturi L, Amin AS. Enzyme replacement therapy in Gaucher disease. Indian Pediatr. 2001;38:686\u2013688.","journal-title":"Indian Pediatr"},{"key":"128_CR9","first-page":"735","volume":"33","author":"M. Kaur","year":"1996","unstructured":"Kaur M, Kabra M, Kher A, Naik G, Bharucha BA, Verma IC. Clinical and enzyme studies in Gaucher disease. Indian Pediatr. 1996;33:735\u2013738.","journal-title":"Indian Pediatr"},{"key":"128_CR10","first-page":"307","volume":"37","author":"M. Feroze","year":"1994","unstructured":"Feroze M, Arvindan KP, Jose L. Gaucher disease among Mappila Muslims of Malabar. Indian J Pathol Microbiol 1994;37:307\u2013311.","journal-title":"Indian J Pathol Microbiol"},{"key":"128_CR11","first-page":"410","volume":"57","author":"A.L. Patel","year":"2009","unstructured":"Patel AL, Shaikh WA, Khobragade AK, Soni HG, Joshi AS, Sahasrabudhe GS, et al. Gaucher disease. J Assoc Phys India. 2009;57;410\u2013411.","journal-title":"J Assoc Phys India"},{"key":"128_CR12","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jpeds.2006.10.062","volume":"150","author":"T.A. Burrow","year":"2007","unstructured":"Burrow TA, Cohen MB, Bokulic R, Deutsch G, Choudhary A, Falcone RA Jr, et al. Gaucher disease: progressive mesenteric and mediastinal lymphadenopathy despite enzyme therapy. J Pediatr. 2007;150:202\u2013226.","journal-title":"J Pediatr"},{"key":"128_CR13","doi-asserted-by":"crossref","first-page":"33","DOI":"10.7326\/0003-4819-122-1-199501010-00005","volume":"122","author":"G.A. Grabowski","year":"1995","unstructured":"Grabowski GA, Barton NW, Pastores G. Dambrosia JM, Banerjee TK, McKee MA, et al. Enzyme therapy in type 1 Gaucher disease: comparative efficacy of mannoseterminated glucocerebrosidase from natural and recombinant sources. Ann Intern Med. 1995;122:33\u201339.","journal-title":"Ann Intern Med"},{"key":"128_CR14","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1203\/00006450-199205000-00019","volume":"31","author":"P. Tsai","year":"1992","unstructured":"Tsai P, Lipton JM, Sahdev I, Najfeld V, Rankin LR, Slyper AH, et al. Allogenic bone marrow transplantation in severe Gaucher disease. Pediatr Res. 1992;31:503\u2013507.","journal-title":"Pediatr Res"},{"key":"128_CR15","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0140-6736(87)91673-4","volume":"1","author":"J.R. Hobbs","year":"1987","unstructured":"Hobbs JR, Jones KH, Shah PJ, Lindsay I, Hancock M. Beneficial effect of pre-transplant splenectomy on displacement bone marrow transplantation for Gaucher\u2019s syndrome. Lancet. 1987;1:1111\u20131115.","journal-title":"Lancet"},{"key":"128_CR16","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1182\/blood.V82.2.408.408","volume":"82","author":"G.M. Pastores","year":"1993","unstructured":"Pastores GM, Sibille AR, Grabowski GA. Enzyme therapy in Gaucher disease type 1: dosage efficacy and adverse effects in 33 patients treated for 6 to 24 months. Blood. 1993;82:408\u2013416.","journal-title":"Blood"},{"key":"128_CR17","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ymgme.2006.09.003","volume":"90","author":"K. Starzyk","year":"2007","unstructured":"Starzyk K, Richards S. Yee J, Smith SE, Kingma W. The long-term international safety experience of imiglucerase therapy for Gaucher disease. Mol Genet Metab. 2007;90:157\u2013163.","journal-title":"Mol Genet Metab"},{"key":"128_CR18","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1542\/peds.2007-2144","volume":"122","author":"H. Andersson","year":"2008","unstructured":"Andersson H, Kaplan P, Kacena K, Yee J. Eight-year clinical outcomes of long-term enzyme replacement therapy for 884 children with Gaucher disease type 1. Pediatrics. 2008;122;1182\u20131190.","journal-title":"Pediatrics"}],"container-title":["Indian Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13312-011-0128-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13312-011-0128-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13312-011-0128-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T23:00:40Z","timestamp":1593212440000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13312-011-0128-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":18,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["128"],"URL":"https:\/\/doi.org\/10.1007\/s13312-011-0128-4","relation":{},"ISSN":["0019-6061","0974-7559"],"issn-type":[{"value":"0019-6061","type":"print"},{"value":"0974-7559","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}